The obsession with reducing public spending on prescription drugs, which takes the form of constantly falling price caps, bulk purchasing strategies and reimbursement restrictions, entails numerous unintended consequences, especially for the health of Canadians. These are the findings of a new study from the Montreal Economic Institute (MEI).
|Part 3: The Underestimated Benefits of “Me-Too” Drugs (Huffington Post, June 20, 2013)
Part 2: Paying Less for Prescription Drugs? Bad Idea (Huffington Post, June 19, 2013)
Part 1: Drug Rationing Is the Wrong Prescription (Huffington Post, June 18, 2013)
The Nasty Side Effects of a National Drug Plan (Huffington Post, June 5, 2013)
National Pharmascare (Financial Post, June 4, 2013)
|Interview with Yanick Labrie, Economist at the MEI (570News, June 5, 2013)||Interview (in French) with Yanick Labrie, Economist at the MEI (Argent, June 5, 2013)|